Peroxisome proliferator-activated receptor-gamma activation inhibits tumor progression in non-small-cell lung cancer. (Q40601264)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:14712215%20AND%20SRC:MED&resulttype=core&format=json

17 November 2019

title

Peroxisome proliferator-activated receptor-gamma activation inhibits tumor progression in non-small-cell lung cancer (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:14712215%20AND%20SRC:MED&resulttype=core&format=json

17 November 2019

1 reference

Venkateshwar G Keshamouni

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:14712215%20AND%20SRC:MED&resulttype=core&format=json

17 November 2019

Gregory P. Kalemkerian

6

object named as

Gregory P Kalemkerian

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:14712215%20AND%20SRC:MED&resulttype=core&format=json

17 November 2019

author name string

Raju C Reddy

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:14712215%20AND%20SRC:MED&resulttype=core&format=json

17 November 2019

Douglas A Arenberg

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:14712215%20AND%20SRC:MED&resulttype=core&format=json

17 November 2019

Binju Joel

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:14712215%20AND%20SRC:MED&resulttype=core&format=json

17 November 2019

Victor J Thannickal

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:14712215%20AND%20SRC:MED&resulttype=core&format=json

17 November 2019

Theodore J Standiford

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:14712215%20AND%20SRC:MED&resulttype=core&format=json

17 November 2019

language of work or name

English

0 references

publication date

1 January 2004

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:14712215%20AND%20SRC:MED&resulttype=core&format=json

17 November 2019

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:14712215%20AND%20SRC:MED&resulttype=core&format=json

17 November 2019

volume

23

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:14712215%20AND%20SRC:MED&resulttype=core&format=json

17 November 2019

issue

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:14712215%20AND%20SRC:MED&resulttype=core&format=json

17 November 2019

page(s)

100-108

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:14712215%20AND%20SRC:MED&resulttype=core&format=json

https://scigraph.springernature.com/pub.10.1038/sj.onc.1206885

17 November 2019

exact match

0 references

cites work

The mechanisms of action of PPARs

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1206885

Ligands for peroxisome proliferator-activated receptorgamma and retinoic acid receptor inhibit growth and induce apoptosis of human breast cancer cells in vitro and in BNX mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1206885

Degradation of the peroxisome proliferator-activated receptor gamma is linked to ligand-dependent activation

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1206885

Subtype- and response element-dependent differences in transactivation by peroxisome proliferator-activated receptors alpha and gamma

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1206885

Mechanism of 17-beta-estradiol-induced Erk1/2 activation in breast cancer cells. A role for HER2 AND PKC-delta

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1206885

Proteasome-dependent degradation of the human estrogen receptor

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1206885

PPARgamma ligands inhibit primary tumor growth and metastasis by inhibiting angiogenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1206885

Activated Raf-1 causes growth arrest in human small cell lung cancer cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1206885

The peroxisome proliferator-activated receptor delta, an integrator of transcriptional repression and nuclear receptor signaling

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1206885

Hyperexpression of mitogen-activated protein kinase in human breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1206885

Retinoic acid induces proteasome-dependent degradation of retinoic acid receptor alpha (RARalpha) and oncogenic RARalpha fusion proteins

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1206885

Proteasome-mediated proteolysis of estrogen receptor: a novel component in autologous down-regulation

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1206885

7 January 2021

Antiapoptotic role of PPARbeta in keratinocytes via transcriptional control of the Akt1 signaling pathway.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1206885

7 January 2021

Implication of proteasome in estrogen receptor degradation

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1206885

7 January 2021

Cells’ Perception of Position in a Concentration Gradient

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1206885

7 January 2021

Functional PPAR-gamma receptor is a novel therapeutic target for ACTH-secreting pituitary adenomas

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1206885

7 January 2021

PPAR-gamma agonists inhibit production of monocyte inflammatory cytokines

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1206885

7 January 2021

Suppression of cyclin-dependent kinase 4 during induced differentiation of erythroleukemia cells

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1206885

7 January 2021

Temporal and quantitative regulation of mitogen-activated protein kinase (MAPK) modulates cell motility and invasion

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1206885

7 January 2021

A human peroxisome-proliferator-activated receptor-gamma is activated by inducers of adipogenesis, including thiazolidinedione drugs

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1206885

7 January 2021

In situ visualization of intratumor growth factor signaling: immunohistochemical localization of activated ERK/MAP kinase in glial neoplasms

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1206885

7 January 2021

MAP kinase kinase kinase, MAP kinase kinase and MAP kinase

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1206885

7 January 2021

Specificity of receptor tyrosine kinase signaling: transient versus sustained extracellular signal-regulated kinase activation

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1206885

7 January 2021

Terminal differentiation of human breast cancer through PPAR gamma

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1206885

7 January 2021

Oxidized LDL regulates macrophage gene expression through ligand activation of PPARgamma

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1206885

7 January 2021

The MAP kinase cascade is essential for diverse signal transduction pathways

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1206885

7 January 2021

The peroxisome proliferator-activated receptor-gamma is a negative regulator of macrophage activation

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1206885

7 January 2021

Differentiation and reversal of malignant changes in colon cancer through PPARgamma

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1206885

7 January 2021

Loss-of-Function Mutations in PPARγ Associated with Human Colon Cancer

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1206885

7 January 2021

G1 phase progression: cycling on cue

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1206885

7 January 2021

PPAR-gamma: adipogenic regulator and thiazolidinedione receptor

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1206885

7 January 2021

Adipogenesis and obesity: rounding out the big picture

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1206885

7 January 2021

Evidence for enhanced ubiquitin-mediated proteolysis of the chicken progesterone receptor by progesterone

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1206885

7 January 2021

Stimulation of adipogenesis in fibroblasts by PPAR gamma 2, a lipid-activated transcription factor

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1206885

7 January 2021

PPARgamma promotes monocyte/macrophage differentiation and uptake of oxidized LDL

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1206885

7 January 2021

Inhibition of cellular proliferation through IkappaB kinase-independent and peroxisome proliferator-activated receptor gamma-dependent repression of cyclin D1.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1206885

7 January 2021

Differentiation Therapy of Acute Promyelocytic Leukemia with Tretinoin (All-trans-Retinoic Acid)

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1206885

7 January 2021

Hepatic dysfunction associated with troglitazone

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1206885

7 January 2021

Identifiers

DOI

10.1038/SJ.ONC.1206885

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:14712215%20AND%20SRC:MED&resulttype=core&format=json

Dimensions Publication ID

17 November 2019

1035035633

0 references

1 reference